Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Using Google Trends to investigate global COPD awareness.

Boehm A, Pizzini A, Sonnweber T, Loeffler-Ragg J, Lamina C, Weiss G, Tancevski I.

Eur Respir J. 2019 Aug 8;54(2). pii: 1901339. doi: 10.1183/13993003.01339-2019. Print 2019 Aug. No abstract available.

PMID:
31395673
2.

Assessing global COPD awareness with Google Trends.

Boehm A, Pizzini A, Sonnweber T, Loeffler-Ragg J, Lamina C, Weiss G, Tancevski I.

Eur Respir J. 2019 Jun 27;53(6). pii: 1900351. doi: 10.1183/13993003.00351-2019. Print 2019 Jun.

PMID:
31097517
3.

The impact of bacteremia on lipoprotein concentrations and patient's outcome: a retrospective analysis.

Pizzini A, Kurz K, Orth-Hoeller D, Fille M, Rabensteiner J, Lunger F, Lunger L, Tschurtschenthaler C, Tancevski I, Krause R, Lass-Floerl C, Weiss G, Bellmann-Weiler R.

Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1279-1286. doi: 10.1007/s10096-019-03543-w. Epub 2019 Apr 13.

4.

The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review.

Pizzini A, Lunger L, Sonnweber T, Weiss G, Tancevski I.

Nutrients. 2018 Dec 2;10(12). pii: E1864. doi: 10.3390/nu10121864. Review.

5.

Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases.

Sonnweber T, Pizzini A, Nairz M, Weiss G, Tancevski I.

Int J Mol Sci. 2018 Oct 23;19(11). pii: E3285. doi: 10.3390/ijms19113285. Review.

6.

The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension.

Sonnweber T, Nairz M, Theurl I, Petzer V, Tymoszuk P, Haschka D, Rieger E, Kaessmann B, Deri M, Watzinger K, Steringer-Mascherbauer R, Tancevski I, Weiss G, Löffler-Ragg J.

PLoS One. 2018 Aug 30;13(8):e0203396. doi: 10.1371/journal.pone.0203396. eCollection 2018.

7.

The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review.

Pizzini A, Lunger L, Demetz E, Hilbe R, Weiss G, Ebenbichler C, Tancevski I.

Nutrients. 2017 Oct 6;9(10). pii: E1099. doi: 10.3390/nu9101099. Review.

8.

The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism.

Demetz E, Schroll A, Auer K, Heim C, Patsch JR, Eller P, Theurl M, Theurl I, Theurl M, Seifert M, Lener D, Stanzl U, Haschka D, Asshoff M, Dichtl S, Nairz M, Huber E, Stadlinger M, Moschen AR, Li X, Pallweber P, Scharnagl H, Stojakovic T, März W, Kleber ME, Garlaschelli K, Uboldi P, Catapano AL, Stellaard F, Rudling M, Kuba K, Imai Y, Arita M, Schuetz JD, Pramstaller PP, Tietge UJF, Trauner M, Norata GD, Claudel T, Hicks AA, Weiss G, Tancevski I.

Cell Metab. 2014 Nov 4;20(5):787-798. doi: 10.1016/j.cmet.2014.09.004.

9.

Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.

Theurl M, Schgoer W, Albrecht-Schgoer K, Lener D, Wolf D, Wolf M, Demetz E, Tymoszuk P, Tancevski I, Fischer-Colbrie R, Franz WM, Marschang P, Kirchmair R.

Cardiovasc Res. 2015 Jan 1;105(1):96-106. doi: 10.1093/cvr/cvu237. Epub 2014 Nov 5.

PMID:
25377726
10.

'Ride on the ferrous wheel'--the cycle of iron in macrophages in health and disease.

Nairz M, Schroll A, Demetz E, Tancevski I, Theurl I, Weiss G.

Immunobiology. 2015 Feb;220(2):280-94. doi: 10.1016/j.imbio.2014.09.010. Epub 2014 Sep 16. Review.

PMID:
25240631
11.

Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2.

Tancevski I, Nairz M, Duwensee K, Auer K, Schroll A, Heim C, Feistritzer C, Hoefer J, Gerner RR, Moschen AR, Heller I, Pallweber P, Li X, Theurl M, Demetz E, Wolf AM, Wolf D, Eller P, Ritsch A, Weiss G.

EMBO Mol Med. 2014 Jun;6(6):810-20. doi: 10.1002/emmm.201303415. Epub 2014 Apr 6.

12.

Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity.

Thoeni CE, Vogel GF, Tancevski I, Geley S, Lechner S, Pfaller K, Hess MW, Müller T, Janecke AR, Avitzur Y, Muise A, Cutz E, Huber LA.

Traffic. 2014 Jan;15(1):22-42. doi: 10.1111/tra.12131. Epub 2013 Nov 19.

13.

Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits.

Demetz E, Tancevski I, Duwensee K, Stanzl U, Huber E, Heim C, Handle F, Theurl M, Schroll A, Tailleux A, Dietrich H, Patsch JR, Eller P, Ritsch A.

Atherosclerosis. 2012 Jun;222(2):360-6. doi: 10.1016/j.atherosclerosis.2012.03.012. Epub 2012 Mar 23.

14.

Atrioesophageal fistula after percutaneous transcatheter ablation of atrial fibrillation.

Tancevski I, Hintringer F, Stuehlinger M, Gassner EM, Bonaros N, Mueller LC, Mair J.

Circulation. 2012 Feb 21;125(7):966. doi: 10.1161/CIRCULATIONAHA.111.044438. No abstract available.

PMID:
22354977
15.

Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein.

Duwensee K, Schwaiger S, Tancevski I, Eller K, van Eck M, Markt P, Linder T, Stanzl U, Ritsch A, Patsch JR, Schuster D, Stuppner H, Bernhard D, Eller P.

Atherosclerosis. 2011 Nov;219(1):109-15. doi: 10.1016/j.atherosclerosis.2011.07.023. Epub 2011 Jul 21.

16.

Thyromimetics: a journey from bench to bed-side.

Tancevski I, Rudling M, Eller P.

Pharmacol Ther. 2011 Jul;131(1):33-9. doi: 10.1016/j.pharmthera.2011.04.003. Epub 2011 Apr 12. Review.

PMID:
21504761
17.

Sobetirome: a selective thyromimetic for the treatment of dyslipidemia.

Tancevski I, Demetz E, Eller P.

Recent Pat Cardiovasc Drug Discov. 2011 Jan;6(1):16-9. Review.

PMID:
21208155
18.

Cholesteryl ester transfer protein in patients with coronary heart disease.

Duwensee K, Breitling LP, Tancevski I, Rothenbacher D, Demetz E, Patsch JR, Ritsch A, Eller P, Brenner H.

Eur J Clin Invest. 2010 Jul;40(7):616-22. doi: 10.1111/j.1365-2362.2010.02313.x. Epub 2010 May 23.

PMID:
20497463
19.

Letter by Eller et al regarding article, "Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland".

Eller K, Tancevski I, Eller P.

Circulation. 2010 Apr 13;121(14):e377. doi: 10.1161/CIR.0b013e3181daaced. No abstract available.

PMID:
20385959
20.

The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice.

Tancevski I, Demetz E, Eller P, Duwensee K, Hoefer J, Heim C, Stanzl U, Wehinger A, Auer K, Karer R, Huber J, Schgoer W, Van Eck M, Vanhoutte J, Fievet C, Stellaard F, Rudling M, Patsch JR, Ritsch A.

PLoS One. 2010 Jan 15;5(1):e8722. doi: 10.1371/journal.pone.0008722.

21.

Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.

Ritsch A, Scharnagl H, Eller P, Tancevski I, Duwensee K, Demetz E, Sandhofer A, Boehm BO, Winkelmann BR, Patsch JR, März W.

Circulation. 2010 Jan 26;121(3):366-74. doi: 10.1161/CIRCULATIONAHA.109.875013. Epub 2010 Jan 11.

22.

Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.

Schgoer W, Theurl M, Jeschke J, Beer AG, Albrecht K, Gander R, Rong S, Vasiljevic D, Egger M, Wolf AM, Frauscher S, Koller B, Tancevski I, Patsch JR, Schratzberger P, Piza-Katzer H, Ritsch A, Bahlmann FH, Fischer-Colbrie R, Wolf D, Kirchmair R.

Circ Res. 2009 Nov 6;105(10):994-1002. doi: 10.1161/CIRCRESAHA.109.199513. Epub 2009 Oct 1.

PMID:
19797703
23.

The resurgence of thyromimetics as lipid-modifying agents.

Tancevski I, Eller P, Patsch JR, Ritsch A.

Curr Opin Investig Drugs. 2009 Sep;10(9):912-8. Review.

24.

Influence of aspirin on SR-BI expression in human carotid plaques.

Wehinger A, Tancevski I, Seiler R, Frotschnig SM, Frantz S, Huber J, Eller P, Schgoer W, Foeger B, Patsch JR, Ritsch A.

Atherosclerosis. 2009 Sep;206(1):234-8. doi: 10.1016/j.atherosclerosis.2009.01.034. Epub 2009 Feb 3.

25.

The thyromimetic T-0681 protects from atherosclerosis.

Tancevski I, Wehinger A, Demetz E, Hoefer J, Eller P, Huber E, Stanzl U, Duwensee K, Auer K, Schgoer W, Kuhn V, Fievet C, Stellaard F, Rudling M, Foeger B, Patsch JR, Ritsch A.

J Lipid Res. 2009 May;50(5):938-44. doi: 10.1194/jlr.M800553-JLR200. Epub 2008 Dec 22.

26.

Sweet heart block.

Eller P, Hochegger K, Tancevski I, Pechlaner C, Patsch JR.

Circulation. 2008 Jul 15;118(3):319. doi: 10.1161/CIRCULATIONAHA.108.766071. No abstract available.

PMID:
18625907
27.

The K121Q polymorphism of ENPP1 and peripheral arterial disease.

Eller P, Schgoer W, Mueller T, Tancevski I, Demetz E, Duwensee K, Ritsch A, Haltmayer M, Patsch JR.

Heart Vessels. 2008 Mar;23(2):104-7. doi: 10.1007/s00380-007-1014-9. Epub 2008 Apr 4.

PMID:
18389334
28.

Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.

Tancevski I, Wehinger A, Demetz E, Eller P, Duwensee K, Huber J, Hochegger K, Schgoer W, Fievet C, Stellaard F, Rudling M, Patsch JR, Ritsch A.

Endocrinology. 2008 Jul;149(7):3708-12. doi: 10.1210/en.2007-1387. Epub 2008 Apr 3.

29.

Images in cardiovascular medicine. Malicious licorice.

Tancevski I, Eller P, Spiegel M, Kirchmair R, Patsch JR.

Circulation. 2008 Apr 1;117(13):e299. doi: 10.1161/CIRCULATIONAHA.107.733097. No abstract available.

PMID:
18378620
30.

The MTP -493TT genotype is associated with peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) Study.

Schgoer W, Eller P, Mueller T, Tancevski I, Wehinger A, Ulmer H, Sandhofer A, Ritsch A, Haltmayer M, Patsch JR.

Clin Biochem. 2008 Jun;41(9):712-6. doi: 10.1016/j.clinbiochem.2008.02.007. Epub 2008 Feb 21.

PMID:
18325332
31.

Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure.

Eller P, Hochegger K, Feuchtner GM, Zitt E, Tancevski I, Ritsch A, Kronenberg F, Rosenkranz AR, Patsch JR, Mayer G.

Nephrol Dial Transplant. 2008 Jan;23(1):321-7. Epub 2007 Sep 10.

PMID:
17848394
32.

Scavenger receptor class B type I polymorphisms and peripheral arterial disease.

Ritsch A, Sonderegger G, Sandhofer A, Stanzl U, Tancevski I, Eller P, Schgoer W, Wehinger A, Mueller T, Haltmayer M, Patsch JR.

Metabolism. 2007 Aug;56(8):1135-41. Erratum in: Metabolism. 2007 Nov;56(11):1599. Sonderegger, Gudron [corrected to Sonderegger, Gudrun]; Stanzl, Ursala [corrected to Stanzl, Ursula]; Patsch, Joseph R [corrected to Patsch, Josef R].

PMID:
17618962
33.

Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis.

Schgoer W, Mueller T, Jauhiainen M, Wehinger A, Gander R, Tancevski I, Salzmann K, Eller P, Ritsch A, Haltmayer M, Ehnholm C, Patsch JR, Foeger B.

Atherosclerosis. 2008 Jan;196(1):219-26. Epub 2007 Jun 5.

PMID:
17553507
34.

Phospholipid transfer protein augments apoptosis in THP-1-derived macrophages induced by lipolyzed hypertriglyceridemic plasma.

Wehinger A, Tancevski I, Schgoer W, Eller P, Hochegger K, Morak M, Hermetter A, Ritsch A, Patsch JR, Foeger B.

Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):908-15. Epub 2007 Feb 1.

PMID:
17272752
35.

Hepatic ENPP1 expression is induced in diabetic rabbits.

Eller P, Hochegger K, Wehinger A, Tancevski I, Schgoer W, Ritsch A, Patsch JR.

Mamm Genome. 2006 Aug;17(8):886-91. Epub 2006 Aug 4.

PMID:
16897338
36.

Aspirin regulates expression and function of scavenger receptor-BI in macrophages: studies in primary human macrophages and in mice.

Tancevski I, Wehinger A, Schgoer W, Eller P, Cuzzocrea S, Foeger B, Patsch JR, Ritsch A.

FASEB J. 2006 Jul;20(9):1328-35.

PMID:
16816107
37.

Comment on 'Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits' by Zhao et al. (Clin Chim Acta 2006; 365: 119-24).

Tancevski I, Ritsch A.

Clin Chim Acta. 2006 Nov;373(1-2):193; author reply 194. Epub 2006 May 13. No abstract available.

PMID:
16797520
38.

In vivo application of adenoviral vectors purified by a Taqman Real Time PCR-supported chromatographic protocol.

Tancevski I, Wehinger A, Patsch JR, Ritsch A.

Int J Biol Macromol. 2006 Aug 15;39(1-3):77-82. Epub 2006 Mar 10.

PMID:
16530264
39.

Hepatic lipase polymorphism and increased risk of peripheral arterial disease.

Eller P, Schgoer W, Mueller T, Tancevski I, Wehinger A, Ulmer H, Foeger B, Haltmayer M, Ritsch A, Patsch JR.

J Intern Med. 2005 Oct;258(4):344-8.

40.

Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I.

Tancevski I, Frank S, Massoner P, Stanzl U, Schgoer W, Wehinger A, Fievet C, Eller P, Patsch JR, Ritsch A.

J Mol Med (Berl). 2005 Nov;83(11):927-32. Epub 2005 Aug 24.

PMID:
16133421
41.

Src tyrosine kinase-dependent migratory effects of antithrombin in leukocytes.

Feistritzer C, Mosheimer BA, Tancevski I, Kaneider NC, Sturn DH, Patsch JR, Wiedermann CJ.

Exp Cell Res. 2005 Apr 15;305(1):214-20.

PMID:
15777801
42.

Molecular characterization of rabbit scavenger receptor class B types I and II: portal to central vein gradient of expression in the liver.

Ritsch A, Tancevski I, Schgoer W, Pfeifhofer C, Gander R, Eller P, Foeger B, Stanzl U, Patsch JR.

J Lipid Res. 2004 Feb;45(2):214-22. Epub 2003 Nov 1.

Supplemental Content

Loading ...
Support Center